Exchange: NASDAQ·Updated 07:30 PM EST

About MBX

About

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
63

Frequently Asked Questions

Advertisement|Remove ads.